Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT05313945
Recruiting Not applicable

Evaluation Patient Satisfaction After Passive Bladder Catheter Removal Compared to Active Removal

NCT05313945 · tracked via the Priya Life Science France tracker
Sponsor
Hospices Civils de Lyon
Phase
Not applicable
Started
2022-07-21
Last updated
2026-03-16

Condition(s) studied

Urologic Diseases

Investigational drug(s) / intervention(s)

Passive indwelling urinary catheter removalActive indwelling catheter removal by a nurse

Passive indwelling urinary catheter removal: After washing the patient's perineal area with water and mild soap, the nurse deflates the indwelling urinary catheter balloon and instructs the patient to take a shower (standing). During this time, the catheter will fall under gravity.

Active indwelling catheter removal by a nurse: After washing the patient's perineal area with water and mild soap, the nurse deflates the balloon and removes the catheter from the urethra by manual traction.

Study summary

In usual practice, the removal of the bladder catheter is performed by a nurse a few days after the surgery. The nurse deflates the balloon and removes the catheter from the urethra by manual traction. To date, there are no solid data on the impact of passive catheter removal on patient satisfaction.

It is therefore necessary to estimate the effect on patient satisfaction of active catheter removal by a nurse versus passive catheter removal under gravity. The effect on pain and anxiety will also be compared between the two techniques. The methodology used was that of an open-label randomized controlled trial.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Male ≥ 18 years old 2. With an indwelling urinary catheter placed after any of the following procedures: A uro-endoscopic surgery from the list below: * Endoscopic prostate resection (or transurethral prostate resection). * Laser prostate enucleation * Prostate thermotherapy by radiofrequency * A high-intensity focused ultrasound treatment for prostate cancer * Cervico-prostatic incision or internal urethrotomy * Endoscopic/Transurethral Resection of Bladder Tumor (TURBT) * Surgical treatment of bladder stones, ureter stones (rigid ureteroscopy) and kidney stones (flexible ureteroscopy with laser stone fragmentation) 3. Patient who has given written consent to participate Exclusion Criteria: 1. Patient who is unable to perform intimate hygiene alone in a standing position 2. Patient with a painful genital lesion 3. Patient with an extended pelvic pathology 4. Need to remove the indwelling urinary catheter at the patient's home instead of hospital 5. Patient under guardianship or curator 6. Patient unable to understand the objectives of the study or unwilling to comply with postoperative instructions

Primary outcome measure(s)

  • Patient satisfaction score — Within one hour after indwelling urinary catheter removal at day 0
    Patient satisfaction score using a numerical rating scale (NRS) from the minimum value 0 (The worse score) to the maximum value 10 (The better Score)

Trial sites (2)

FacilityCityRegionStatus
CHU Grenoble Grenoble France Recruiting
Hôpita Edouard Herriot Lyon France Recruiting

More Hospices Civils de Lyon trials in France

Dance-therapy and Chronic Pain Recruiting
Immunoparalysis After Pancreaticoduodenectomy Recruiting
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes Recruiting
Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery Recruiting
Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort Recruiting

Other trials for the same condition

Long Term Extension Study in Patients With Primary Hyperoxaluria Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05313945 on ClinicalTrials.gov ↗ ← All trials in France